{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T18:13:33Z","timestamp":1783793613748,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T00:00:00Z","timestamp":1755388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T00:00:00Z","timestamp":1755388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1245\/s10434-025-18024-y","type":"journal-article","created":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T12:58:34Z","timestamp":1755435514000},"page":"7644-7651","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Oncologic Outcomes of Intraoperative Autologous Blood Transfusion for Major Oncologic Resection"],"prefix":"10.1245","volume":"32","author":[{"given":"Chelsea","family":"Powell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"van Buskirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth B.","family":"Habermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Houdek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timucin","family":"Taner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Heimbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3654-8601","authenticated-orcid":false,"given":"Cornelius","family":"Thiels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,17]]},"reference":[{"issue":"13","key":"18024_CR1","first-page":"e642","volume":"107","author":"J Montroy","year":"2020","unstructured":"Montroy J, et al. The top 20 surgical procedures associated with the highest risk for blood transfusion. Br J Surg. 2020;107(13):e642\u20133.","journal-title":"Br J Surg"},{"issue":"6","key":"18024_CR2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/jamasurg.2015.5094","volume":"151","author":"BL Ecker","year":"2016","unstructured":"Ecker BL, et al. Blood transfusion in major abdominal surgery for malignant tumors: a trend analysis using the National Surgical Quality Improvement Program. JAMA Surg. 2016;151(6):518\u201325.","journal-title":"JAMA Surg"},{"issue":"5","key":"18024_CR3","doi-asserted-by":"crossref","first-page":"931-7","DOI":"10.1016\/j.jamcollsurg.2008.11.019","volume":"208","author":"AC Bernard","year":"2009","unstructured":"Bernard AC, et al. Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg. 2009;208(5):931-7-937 e1-2.","journal-title":"J Am Coll Surg"},{"issue":"2","key":"18024_CR4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/ALN.0b013e3182054d06","volume":"114","author":"LG Glance","year":"2011","unstructured":"Glance LG, et al. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology. 2011;114(2):283\u201392.","journal-title":"Anesthesiology"},{"issue":"1","key":"18024_CR5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archsurg.2011.790","volume":"147","author":"VA Ferraris","year":"2012","unstructured":"Ferraris VA, et al. Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg. 2012;147(1):49\u201355.","journal-title":"Arch Surg"},{"issue":"3","key":"18024_CR6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.surg.2012.06.008","volume":"152","author":"WB Al-Refaie","year":"2012","unstructured":"Al-Refaie WB, et al. Blood transfusion and cancer surgery outcomes: a continued reason for concern. Surgery. 2012;152(3):344\u201354.","journal-title":"Surgery"},{"issue":"4","key":"18024_CR7","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.soard.2019.01.023","volume":"15","author":"RM Higgins","year":"2019","unstructured":"Higgins RM, et al. Perioperative blood transfusion increases risk of surgical site infection after bariatric surgery. Surg Obes Relat Dis. 2019;15(4):582\u20137.","journal-title":"Surg Obes Relat Dis"},{"issue":"5","key":"18024_CR8","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.athoracsur.2013.12.044","volume":"97","author":"T Wang","year":"2014","unstructured":"Wang T, et al. Perioperative blood transfusion is associated with worse clinical outcomes in resected lung cancer. Ann Thorac Surg. 2014;97(5):1827\u201337.","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"18024_CR9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s00268-016-3730-8","volume":"41","author":"M Reeh","year":"2017","unstructured":"Reeh M, et al. Allogenic blood transfusion is associated with poor perioperative and long-term outcome in esophageal cancer. World J Surg. 2017;41(1):208\u201315.","journal-title":"World J Surg"},{"issue":"7","key":"18024_CR10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/000313481708300735","volume":"83","author":"CE Poorman","year":"2017","unstructured":"Poorman CE, et al. Blood transfusion and survival for resected adrenocortical carcinoma: a study from the United States Adrenocortical Carcinoma Group. Am Surg. 2017;83(7):761\u20138.","journal-title":"Am Surg"},{"issue":"1","key":"18024_CR11","doi-asserted-by":"crossref","first-page":"13345","DOI":"10.1038\/s41598-018-31662-5","volume":"8","author":"HL Wu","year":"2018","unstructured":"Wu HL, et al. The impact of blood transfusion on recurrence and mortality following colorectal cancer resection: a propensity score analysis of 4,030 patients. Sci Rep. 2018;8(1):13345.","journal-title":"Sci Rep"},{"issue":"8","key":"18024_CR12","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/jso.25086","volume":"117","author":"AG Lopez-Aguiar","year":"2018","unstructured":"Lopez-Aguiar AG, et al. Association of perioperative transfusion with survival and recurrence after resection of gallbladder cancer: a 10-institution study from the US Extrahepatic Biliary Malignancy Consortium. J Surg Oncol. 2018;117(8):1638\u201347.","journal-title":"J Surg Oncol"},{"issue":"6","key":"18024_CR13","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1245\/s10434-019-07306-x","volume":"26","author":"AG Lopez-Aguiar","year":"2019","unstructured":"Lopez-Aguiar AG, et al. Association of perioperative transfusion with recurrence and survival after resection of distal cholangiocarcinoma: a 10-institution study from the US Extrahepatic Biliary Malignancy Consortium. Ann Surg Oncol. 2019;26(6):1814\u201323.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"18024_CR14","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1016\/j.jtcvs.2018.12.109","volume":"157","author":"MJ Latif","year":"2019","unstructured":"Latif MJ, et al. Perioperative blood transfusion has a dose-dependent relationship with disease recurrence and survival in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. 2019;157(6):2469-2477 e10.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"18024_CR15","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3390\/jcm9030689","volume":"9","author":"SY Kim","year":"2020","unstructured":"Kim SY, et al. Intraoperative transfusion is independently associated with a worse prognosis in resected pancreatic cancer-a retrospective cohort analysis. J Clin Med. 2020;9(3):689.","journal-title":"J Clin Med"},{"key":"18024_CR16","doi-asserted-by":"crossref","first-page":"1011005","DOI":"10.3389\/fsurg.2022.1011005","volume":"9","author":"W Wang","year":"2022","unstructured":"Wang W, et al. Effects of perioperative blood transfusion in gastric cancer patients undergoing gastrectomy: a systematic review and meta-analysis. Front Surg. 2022;9:1011005.","journal-title":"Front Surg"},{"issue":"1","key":"18024_CR17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/ALN.0000000000000511","volume":"122","author":"JP de Almeida","year":"2015","unstructured":"de Almeida JP, et al. Transfusion requirements in surgical oncology patients: a prospective, randomized controlled trial. Anesthesiology. 2015;122(1):29\u201338.","journal-title":"Anesthesiology"},{"issue":"1","key":"18024_CR18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-0039-1697933","volume":"46","author":"S Abeysiri","year":"2020","unstructured":"Abeysiri S, Chau M, Richards T. Perioperative anemia management. Semin Thromb Hemost. 2020;46(1):8\u201316.","journal-title":"Semin Thromb Hemost"},{"issue":"9","key":"18024_CR19","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1053\/j.jvca.2021.03.011","volume":"35","author":"P Tibi","year":"2021","unstructured":"Tibi P, et al. STS\/SCA\/AmSECT\/SABM Update to the Clinical Practice Guidelines on patient blood management. J Cardiothorac Vasc Anesth. 2021;35(9):2569\u201391.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"9","key":"18024_CR20","first-page":"CD001888","volume":"9","author":"TD Lloyd","year":"2023","unstructured":"Lloyd TD, et al. Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery. Cochrane Database Syst Rev. 2023;9(9):CD001888.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"18024_CR21","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.1975.03240170032013","volume":"231","author":"PB Yaw","year":"1975","unstructured":"Yaw PB, et al. Tumor cells carried through autotransfusionContraindication to intraoperative blood recovery? JAMA. 1975;231(5):490\u20131.","journal-title":"JAMA"},{"issue":"6","key":"18024_CR22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/bjs.1800750627","volume":"75","author":"RF Dale","year":"1988","unstructured":"Dale RF, et al. Separation of malignant cells during autotransfusion. Br J Surg. 1988;75(6):581.","journal-title":"Br J Surg"},{"issue":"6","key":"18024_CR23","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1213\/00000539-199406000-00017","volume":"78","author":"DM Karczewski","year":"1994","unstructured":"Karczewski DM, Lema MJ, Glaves D. The efficiency of an autotransfusion system for tumor cell removal from blood salvaged during cancer surgery. Anesth Analg. 1994;78(6):1131\u20135.","journal-title":"Anesth Analg"},{"issue":"1","key":"18024_CR24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13073-020-00728-3","volume":"12","author":"F Castro-Giner","year":"2020","unstructured":"Castro-Giner F, Aceto N. Tracking cancer progression: from circulating tumor cells to metastasis. Genome Med. 2020;12(1):31.","journal-title":"Genome Med"},{"issue":"1","key":"18024_CR25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/tri.12001","volume":"26","author":"JM Kim","year":"2013","unstructured":"Kim JM, et al. Long-term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter. Transpl Int. 2013;26(1):84\u20139.","journal-title":"Transpl Int"},{"issue":"2","key":"18024_CR26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4240\/wjgs.v8.i2.161","volume":"8","author":"RL Araujo","year":"2016","unstructured":"Araujo RL, et al. Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence? World J Gastrointest Surg. 2016;8(2):161\u20138.","journal-title":"World J Gastrointest Surg"},{"issue":"1","key":"18024_CR27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00423-020-01997-7","volume":"406","author":"MA Pinto","year":"2021","unstructured":"Pinto MA, et al. Impact of intraoperative blood salvage and autologous transfusion during liver transplantation for hepatocellular carcinoma. Langenbecks Arch Surg. 2021;406(1):67\u201374.","journal-title":"Langenbecks Arch Surg"},{"issue":"11","key":"18024_CR28","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1245\/s10434-021-09863-6","volume":"28","author":"T Ivanics","year":"2021","unstructured":"Ivanics T, et al. Blood cell salvage and autotransfusion does not worsen oncologic outcomes following liver transplantation with incidental hepatocellular carcinoma: a propensity score-matched analysis. Ann Surg Oncol. 2021;28(11):6816\u201325.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"18024_CR29","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1111\/tri.14150","volume":"34","author":"OA Nutu","year":"2021","unstructured":"Nutu OA, et al. Safety of intra-operative blood salvage during liver transplantation in patients with hepatocellular carcinoma, a propensity score-matched survival analysis. Transpl Int. 2021;34(12):2887\u201394.","journal-title":"Transpl Int"},{"issue":"6","key":"18024_CR30","doi-asserted-by":"crossref","first-page":"e842","DOI":"10.1097\/SLA.0000000000004866","volume":"276","author":"JH Kwon","year":"2022","unstructured":"Kwon JH, et al. Blood salvage and autotransfusion with single leukoreduction does not increase the risk of tumor recurrence after liver transplantation for advanced hepatocellular carcinoma. Ann Surg. 2022;276(6):e842\u201350.","journal-title":"Ann Surg"},{"issue":"3","key":"18024_CR31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.hpb.2021.06.433","volume":"24","author":"TL Sutton","year":"2022","unstructured":"Sutton TL, et al. Intraoperative autologous transfusion and oncologic outcomes in liver transplantation for hepatocellular carcinoma: a propensity matched analysis. HPB (Oxford). 2022;24(3):379\u201385.","journal-title":"HPB (Oxford)"},{"issue":"11","key":"18024_CR32","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s005950200191","volume":"32","author":"S Motoyama","year":"2002","unstructured":"Motoyama S, et al. Survival advantage of using autologous blood transfusion during surgery for esophageal cancer. Surg Today. 2002;32(11):951\u20138.","journal-title":"Surg Today"},{"issue":"6","key":"18024_CR33","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.urology.2015.09.008","volume":"86","author":"TD Lyon","year":"2015","unstructured":"Lyon TD, et al. Short-term outcomes of intraoperative cell saver transfusion during open partial nephrectomy. Urology. 2015;86(6):1153\u20138.","journal-title":"Urology"},{"issue":"5","key":"18024_CR34","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1503\/cjs.004016","volume":"59","author":"M Elmi","year":"2016","unstructured":"Elmi M, et al. The impact of blood transfusion on perioperative outcomes following gastric cancer resection: an analysis of the American College of Surgeons National Surgical Quality Improvement Program database. Can J Surg. 2016;59(5):322\u20139.","journal-title":"Can J Surg"},{"issue":"12","key":"18024_CR35","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/jhbp.592","volume":"25","author":"S Onoe","year":"2018","unstructured":"Onoe S, et al. Comparison between autologous and homologous blood transfusions in liver resection for biliary tract cancer: a propensity score matching analysis. J Hepatobiliary Pancreat Sci. 2018;25(12):550\u20139.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"3","key":"18024_CR36","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.21037\/tau-20-1265","volume":"10","author":"J Xu","year":"2021","unstructured":"Xu J, Kinnear N, Johns Putra L. Safety efficacy and cost of intra-operative cell salvage during open radical prostatectomy. Transl Androl Urol. 2021;10(3):1241\u20139.","journal-title":"Transl Androl Urol"},{"key":"18024_CR37","doi-asserted-by":"crossref","first-page":"1022426","DOI":"10.3389\/fonc.2022.1022426","volume":"12","author":"X Gao","year":"2022","unstructured":"Gao X, et al. Transfusion of stored autologous blood in patients with low-grade pseudomyxoma peritonei: a retrospective analysis of its safety and outcome. Front Oncol. 2022;12:1022426.","journal-title":"Front Oncol"},{"issue":"9","key":"18024_CR38","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/anae.14331","volume":"73","author":"AA Klein","year":"2018","unstructured":"Klein AA, et al. Association of Anaesthetists guidelines: cell salvage for peri-operative blood conservation 2018. Anaesthesia. 2018;73(9):1141\u201350.","journal-title":"Anaesthesia"},{"issue":"3","key":"18024_CR39","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000330746","volume":"47","author":"D Foltys","year":"2011","unstructured":"Foltys D, et al. Liver transplantation for hepatocellular carcinoma\u2013Is there a risk of recurrence caused by intraoperative blood salvage autotransfusion? Eur Surg Res. 2011;47(3):182\u20137.","journal-title":"Eur Surg Res"},{"issue":"2","key":"18024_CR40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/SLA.0000000000001486","volume":"264","author":"S Han","year":"2016","unstructured":"Han S, et al. Safety of the use of blood salvage and autotransfusion during liver transplantation for hepatocellular carcinoma. Ann Surg. 2016;264(2):339\u201343.","journal-title":"Ann Surg"},{"issue":"10","key":"18024_CR41","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1097\/JS9.0000000000000557","volume":"109","author":"AS Lakha","year":"2023","unstructured":"Lakha AS, et al. Autologous blood transfusion reduces the requirement for perioperative allogenic blood transfusion in patients undergoing major hepatopancreatobiliary surgery: a retrospective cohort study. Int J Surg. 2023;109(10):3078\u201386.","journal-title":"Int J Surg"},{"issue":"1","key":"18024_CR42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/jso.20064","volume":"87","author":"S Motoyama","year":"2004","unstructured":"Motoyama S, et al. Use of autologous instead of allogeneic blood transfusion during esophagectomy prolongs disease-free survival among patients with recurrent esophageal cancer. J Surg Oncol. 2004;87(1):26\u201331.","journal-title":"J Surg Oncol"},{"issue":"19","key":"18024_CR43","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.3390\/cancers14194837","volume":"14","author":"A Murtha-Lemekhova","year":"2022","unstructured":"Murtha-Lemekhova A, et al. Effect of autotransfusion in hcc surgery on survival and recurrence: a systematic review and meta-analysis. Cancers. 2022;14(19):4837.","journal-title":"Cancers"},{"key":"18024_CR44","volume":"13","author":"R Mispelbaum","year":"2022","unstructured":"Mispelbaum R, et al. Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors. Front Immunol. 2022;13:976011.","journal-title":"Front Immunol"},{"issue":"2","key":"18024_CR45","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ijrobp.2008.04.052","volume":"73","author":"SA Bhide","year":"2009","unstructured":"Bhide SA, et al. Anemia during sequential induction chemotherapy and chemoradiation for head and neck cancer: the impact of blood transfusion on treatment outcome. Int J Radiat Oncol Biol Phys. 2009;73(2):391\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"18024_CR46","first-page":"253","volume":"5","author":"G Opelz","year":"1973","unstructured":"Opelz G, et al. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc. 1973;5(1):253\u20139.","journal-title":"Transplant Proc"},{"key":"18024_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/CGM.S32797","volume":"9","author":"HA Goubran","year":"2016","unstructured":"Goubran HA, et al. Impact of transfusion on cancer growth and outcome. Cancer Growth Metastasis. 2016;9:1\u20138.","journal-title":"Cancer Growth Metastasis"},{"key":"18024_CR48","unstructured":"Organ Procurement and Transplantation Network. Guidance to Liver Transplant Programs and the National Liver Review Board for: adult MELD exceptions for transplant oncology. 2025. Available from: https:\/\/optn.transplant.hrsa.gov\/media\/xpdfswdv\/nlrb-guidance_adult-transplant-oncology_feb-2025.pdf. Accessed 22 May 2025."},{"issue":"12","key":"18024_CR49","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P","volume":"91","author":"JJ Caro","year":"2001","unstructured":"Caro JJ, et al. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer. 2001;91(12):2214\u201321.","journal-title":"Cancer"},{"issue":"5","key":"18024_CR50","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.ijrobp.2004.12.038","volume":"62","author":"S Yovino","year":"2005","unstructured":"Yovino S, et al. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone. Int J Radiat Oncol Biol Phys. 2005;62(5):1438\u201343.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18024_CR51","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12876-015-0364-5","volume":"15","author":"B Liu","year":"2015","unstructured":"Liu B, et al. Excessive intraoperative blood loss independently predicts recurrence of hepatocellular carcinoma after liver transplantation. BMC Gastroenterol. 2015;15:138.","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"18024_CR52","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/SLA.0b013e31819ed22f","volume":"249","author":"SC Katz","year":"2009","unstructured":"Katz SC, et al. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg. 2009;249(4):617\u201323.","journal-title":"Ann Surg"},{"issue":"11","key":"18024_CR53","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.21873\/anticanres.16718","volume":"43","author":"H Watanabe","year":"2023","unstructured":"Watanabe H, et al. Intraoperative blood loss impacts recurrence and survival in patients with locally advanced esophageal cancer. Anticancer Res. 2023;43(11):5173\u20139.","journal-title":"Anticancer Res"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18024-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18024-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18024-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T14:05:38Z","timestamp":1758549938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18024-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,17]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["18024"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18024-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,17]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Cornelius Thiels, D.O., M.B.A. declares unrelated compensation for consulting work with Intera Oncology. Vidit Sharma, M.D. served on the advisory board of ImmunityBio for one day, for which he received compensation. He also purchased ImmunityBio stock and has received an American Urological Association grant for renal cell carcinoma and venous tumor thrombus research.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}